Johnson & Johnson receives a boost of $ 454 million from the US government for the next phase of the Covid vaccine.
Johnson & Johnson and the US Department of Health and Human Services have expanded an agreement to support the next phase of research and development of COVID-19 vaccine candidates, the company said on Saturday.
Under the agreement, the company will commit approximately $ 604 million and the Biomedical Advanced Research and Development Authority of the HHS department will commit approximately $ 454 million to support the ENSEMBLE phase 3 trial evaluating Janssen’s experimental COVID-19 vaccine candidate. as a single dose in up to 60,000 volunteers worldwide. , the company said in a statement
(Except for the title, this story was not edited by GalacticGaming staff and is posted from a syndicated feed.)
